View All Articles Does the Virus Exist? SARS-CoV-2 Has Not Been Isolated? “Biggest Fraud in Medical History” A Review By Prof Michel Chossudovsky Global Research, August 10, 2021 Click here to read the article in your browser. Hell is Empty and the Devils are All Here, William Shakespeare, The Tempest, 1610- 1611   Introduction There is a sequence of outright lies and fabrications used to justify far-reaching policy decisions which in the course of the last 18 months are literally destroying people’s lives Worldwide.  “Fake science” is used to justify confinement, social distancing, the face mask, the prohibition of social gatherings, cultural and sports events, the closure of economic activity, all of which are upheld as a means to repealing the “killer virus”.  Who is this “Killer Virus” which has been personified by both the media and our governments, held responsible for triggering economic and social chaos Worldwide?  You might recall that at the height of the February 2020 financial collapse, “V the Virus” was held responsible for the largest stock market crash since 1929.  Has the “Killer Virus” been Identified. Has SARS-CoV-2 been Isolated? This article will review this contentious issue starting at the outset of the crisis in January 2020. Part of this analysis is based on research conducted in early 2020.  The central question raised in this review is the following: is there reliable evidence provided by the WHO and national health authorities that the alleged SARS-CoV-2 virus has been isolated/purified from an “unadulterated sample taken from a diseased patient”?  While the alleged virus was initially defined as the 2019 novel coronavirus (2019-nCoV) in January 2020, the World Health Organization (WHO) did not have in its possession details regarding the isolation/purification and identity of 2019-nCoV. And because details concerning isolation / purification were not available, the WHO decided to “customize” The Real Time Reverse Transcription Polymerase Chain Reaction (rRT-PCR) Test using the alleged “similar” 2003 SARS virus (subsequently renamed SARS-1) as “a point of reference” for detecting genetic fragments of the novel 2019-nCoV.  What this decision entails is that novel 2019-CoV-2 is NOT a novel virus. It was categorized by the Chinese authorities and the WHO as “similar” to the 2003 SARS-CoV as well as to MERS.  2003 SARS-CoV was subsequently renamed SARS-CoV-1. History: Isolation of the Virus  Chinese Health Authorities The Chinese authorities announced on January 7, 2020 that “a new type of virus” had been identified “similar to the one associated with SARS and MERS” (related report , not original Chinese government source). The underlying method is described below: We prospectively collected and analysed data on patients with laboratory- confirmed 2019-nCoV infection by real-time RT-PCR and next-generation sequencing.  Data were obtained with standardised data collection forms shared by WHO and the International Severe Acute Respiratory and Emerging Infection Consortium from electronic medical records. (emphasis added) The following article entitled “A new coronavirus associated with human respiratory disease in China, (Nature, February 3, 2021) was among the first to report on China’s novel coronavirus: …[We] collected bronchoalveolar lavage fluid (BALF) and performed deep meta-transcriptomic sequencing. The clinical specimen was handled in a biosafety level 3 laboratory at Shanghai Public Health Clinical Center. Total RNA was extracted from 200 μl of BALF and a meta-transcriptomic library was constructed for pair-end (150-bp reads) sequencing using an Illumina MiniSeq as previously described 4,6,7,8. In total, we generated 56,565,928 sequence reads that were de novo-assembled  and screened for potential aetiological agents.  … The genome sequence of this virus, as well as its termini, were determined and confirmed by reverse-transcription PCR (RT–PCR)10 and 5′/3′ rapid amplification of cDNA ends (RACE), respectively. This virus strain was designated as WH-Human 1 coronavirus (WHCV) (and has also been referred to as ‘2019-nCoV’) and its whole genome sequence (29,903 nt) has been assigned GenBank accession number MN908947. The viral genome organization of WHCV was determined by sequence alignment to two representative members of the genus Betacoronavirus: a coronavirus associated with humans (SARS-CoV Tor2, GenBank accession number AY274119) [2003] and a coronavirus associated with bats (bat SL-CoVZC45, GenBank accession number MG772933). (Nature, February 3, 2020) It is unclear from the above quotations as well as from the documents consulted, whether the Chinese health authorities undertook an isolation / purification of a patient’s specimen. US Centre for Disease Control and Prevention (CDC)  Following the Chinese announcement on the 28th of January 2020, the US Centre for Disease Control and Prevention (CDC) stated that the novela corona virus had been isolated. The CDC statement dated January 28th, 2020 (updated December 2020) is unequivocal: SARS-CoV-2, the virus that causes COVID-19, was isolated in the laboratory and is available for research by the scientific and medical community. …. Timeline: On January 20, 2020, CDC received a clinical specimen collected from the first reported U.S. patient infected with SARS-CoV-2. CDC immediately placed the specimen into cell culture to grow a sufficient amount of virus for study. On February 2, 2020, CDC generated enough SARS-CoV-2 grown in cell culture to distribute to medical and scientific researchers. On February 4, 2020, CDC shipped SARS-CoV-2 to the BEI Resources Repository. An article discussing the isolation and characterization of this virus specimen is available in Emerging Infectious Diseases. … One important way that CDC has supported global efforts to study and learn about SARS-CoV-2 in the laboratory was by growing the virus in cell culture and ensuring that it was widely available. Researchers in the scientific and medical community can use virus obtained from this work in their studies. SARS-CoV-2 strains supplied by CDC and other researchers can be requested, free, from the Biodefense and Emerging Infections Research (BEI) Resources Repositoryexternal icon by established institutions that meet BEI requirements.These requirements include maintaining appropriate facilities and safety programs, as well as having the appropriate expertise. BEI supplies organisms and reagents to the broader community of microbiology and infectious disease researchers. (Emphasis added). See also related study which was posted on the CDC website. The CDC Acknowledges that SARS-CoV-2 has not been Isolated. The official CDC document, (dated July 21, 2021) entitled “CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panelreads as follows: Since no quantified virus isolates of the 2019-nCoV were available for CDC use at the time the test was developed [January 2020] and this study conducted, assays designed for detection of the 2019-nCoV RNA were tested with characterized stocks of in vitro transcribed full length RNA (N gene; GenBank accession: MN908947.2) of known titer (RNA copies/µL) spiked into a diluent consisting of a suspension of human A549 cells and viral transport medium (VTM) to mimic clinical specimen. (emphasis added, page 40) Compare the above statement to the CDC January 28th, 2020 advisory confirming the isolation of SARS-CoV-2: On January 20, 2020, CDC received a clinical specimen collected from the first reported U.S. patient infected with SARS-CoV-2. CDC immediately placed the specimen into cell culture to grow a sufficient amount of virus for study. *** See the analysis of CDC responses in the section below on Freedom of Information Requests. The World Health Organization (WHO) Did Not Undertake The Isolation / Purification of a Specimen From the documents quoted below, the Chinese authorities did not provide the WHO with a specimen of isolated / purified SARS-CoV-2. And because details concerning isolation were not available, the WHO decided to “customize” its Real Time Reverse Transcription Polymerase Chain Reaction (rRT-PCR)  test using a so-called isolate of the “similar” 2003 SARS corona virus (subsequently renamed SARS-CoV-1) as “a point of reference” (or proxy) for detecting genetic fragments of the 2019 SARS-CoV-2. The WHO sought the advice of Victor M. Corman, Christian Drosten, et al of the Berlin Virology Institute at Charité Hospital. The study entitled “Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR”) was subsequently submitted to the WHO.  While Corman, Drosten et al’s study confirmed that “several viral genome sequences had been released”, in the case of 2019-nCoV, “virus isolates or samples from infected patients were not available … ” The recommendations to the WHO were as follows: “The genome sequences suggest presence of a virus closely related to the members of a viral species termed severe acute respiratory syndrome (SARS)-related CoV, a species defined by the agent of the 2002/03 outbreak of SARS in humans [3,4]. We report on the the establishment and validation of a diagnostic workflow for 2019-nCoV screening and specific confirmation [using the RT-PCR test], designed in absence of available virus isolates or original patient specimens. Design and validation were enabled by the close genetic relatedness to the 2003 SARS-CoV, and aided by the use of synthetic nucleic acid technology.”  (Eurosurveillance, January 23, 2020, emphasis added). What this bold statement suggests is that the isolation / purification of 2019-nCoV was not required and that “validation” would be enabled by “the close genetic relatedness to the 2003-SARS-CoV.” The recommendations of the Corman- Drosten study (supported and financed by the Gates Foundation) pertaining to the use of the RT-PCR test applied to 2019-nCoV were then firmly endorsed by the Director General of the WHO, Dr. Tedros Adhanom. (For further details see Michel Chossudovsky, E-Book, Chapter II). Freedom of Information: No Record of SARS-CoV-2 Isolation-Purification An important ongoing and detailed investigative project by Christine Massey, M.Sc. of Ontario, Canada is entitled: Freedom of Information Requests: Health/ Science Institutions Worldwide “Have No Record” of SARS-COV-2 Isolation/Purification (work in progress since 2020),  By Fluoride Free Peel, August 04, 2021 A related text shows the list of institutions contacted 90 Health/Science Institutions Globally All Failed to Cite Even 1 Record of “SARS-COV-2” Purification, by Anyone, Anywhere, Ever   By Fluoride Free Peel, August 04, 2021 The investigative report provides detailed documentation based on Freedom of Information (FOI) requests addressed to ninety Health /Science institutions in a large number of countries. The responses to these requests confirm that there is no record of isolation / purification of SARS-CoV-2 “having been performed by anyone, anywhere, ever.” “The 90 Health /Science institutions that have responded thus far have provided and/or cited, in total, zero such records: Our requests [under “freedom of information”] have not been limited to records of isolation performed by the respective institution, or limited to records authored by the respective institution, rather they were open to any records describing “COVID-19 virus” (aka “SARS-COV-2”) isolation/purification performed by anyone, ever, anywhere on the planet.” The Centre for Disease Control and Prevention (CDC) The CDC was contacted by the author of this report in the form of four separate requests: November 2, 2020, March 1, 2021, March 3, 2021, which are reviewed below:   On November 2, 2020. The CDC admitted they have no records of actual isolation/purification by anyone, anywhere, ever, by any method” : USA-CDC-Virus-Isolation-Response-Scrubbed.pdf March 1, 2021: The CDC again made clear that they still have no records of “SARS-COV-2” isolation performed by anyone, anywhere on the planet, ever… just not in so many words. Instead, the CDC absurdly implied that isolation/purification of “SARS-COV-2” would require the replication of a “virus” without host cells and thus is impossible. (The request had nothing to do with replication.) .. https://www.fluoridefreepeel.ca/wp-content/uploads/2021/03/CDC-March-1-2021-SARS-COV-2-Isolation-Response-Redacted.pdf March 3, 2021: CDC again failed to provide/cite any records describing “SARS-COV-2” isolation/purification by anyone anywhere ever… but would no longer simply say so (as they did on November 2nd); instead they gave song and dance citing the study by Harcourt et al. which is the same one posted on CDC’s website: https://www.fluoridefreepeel.ca/wp-content/uploads/2021/03/CDC-March-3-2021-SARS-COV-2-purification-FOI-response.pdf June 7, 2021: CDC admitted they have no record of “SARS-COV-2” purification from a patient sample via maceration, filtration and use of an ultracentrifuge, by anyone, anywhere, ever: https://www.fluoridefreepeel.ca/wp-content/uploads/2021/06/CDC-FOIA-request-response-no-records-SARS-COV-2-purification.pdf Conclusive Results of the Investigation What the author of this incisive and detailed report has confirmed is that: Every institution has failed to provide even 1 record describing the isolation aka purification of any “COVID-19 virus” directly from a patient sample that was not first adulterated with other sources of genetic material. (Those other sources are typically monkey kidney aka “Vero” cells and fetal bovine serum). Here are 5 compilation pdfs containing FOI responses from 79 institutions in 22 countries/jurisdictions, re the isolation/purification/existence of “SARS-COV-2”, as well as emails from authors of studies that claimed to have “isolated the virus” and an email from the Head of the Consultant Laboratory for Diagnostic Electron Microscopy of Infectious Pathogens at Germany’s Robert Koch Institut, last updated July 13, 2021 Screenshot of a selected responses are provided below : New Zealand, Canada, UK. Consult the full archive of letters and responses. This work was undertaken over a period of more than 12 months. Response Public Health England

Published by technofiend1

Kazan- Kazan National Research Technical University Казанский национальный исследовательский технический университет имени А. Н. Туполева he graduated in Economics in 1982

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: